Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Acurx Pharmaceuticals, Inc. (ACXP) had Income from Continuous Operations of $-1.99M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.99M |
|
-- |
|
-- |
|
$2.03M |
|
$-2.03M |
|
$0.04M |
|
$-1.99M |
|
$-1.99M |
|
$-1.99M |
|
|
Income from Continuous Operations |
$-1.99M |
$-1.99M |
|
$-1.99M |
|
$-2.03M |
|
$-2.03M |
|
1.63M |
|
1.63M |
|
$-1.23 |
|
$-1.23 |
|
| Balance Sheet Financials | |
$6.11M |
|
-- |
|
-- |
|
$6.11M |
|
$2.47M |
|
-- |
|
-- |
|
$2.47M |
|
$3.64M |
|
$3.64M |
|
$3.64M |
|
1.80M |
|
| Cash Flow Statement Financials | |
$-5.60M |
|
-- |
|
$7.80M |
|
$3.71M |
|
$5.91M |
|
$2.20M |
|
$1.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-54.79% |
|
-54.79% |
|
-32.64% |
|
-54.79% |
|
$2.02 |
|
$-3.45 |
|
$-3.45 |
|